Biglycan (December 2011) Biglycan as a protein therapeutic for Duchenne Muscular Dystrophy Justin R. Fallon, Department of Neuroscience, Brown University 14 years ago Research & Clinical Trial Webinars,Webinars You may also like Webinar: Exercise and Dystrophinopathy – What Families Need to Know 3 days ago Care Webinars,Webinars exercise,physical therapy Webinar: Ataluren and the Current Regulatory Landscape 1 month ago Webinars ataluren,ptc therapeutics Webinar: Understanding the Expanded Duchenne Natural History Study (eDNHS) 1 month ago Webinars Webinar: Dyne Therapeutics — Topline Results from Phase 1/2 DELIVER Trial 3 months ago Research & Clinical Trial Webinars,Webinars dyne therapeutics,DYNE-251 Webinar: Sarepta Therapeutics – Community Update on ELEVIDYS 4 months ago Research & Clinical Trial Webinars,Webinars elevidys,gene therapy,sarepta Webinar: Capricor Therapeutics — HOPE-3 Community Update 5 months ago Research & Clinical Trial Webinars,Webinars capricor,deramiocel Webinar: Avidity Biosciences – EXPLORE44-OLE® Topline and Functional Data Presentation 6 months ago Research & Clinical Trial Webinars,Webinars avidity biosciences,del-zota Becker Muscular Dystrophy Webinar Series – Part 2: Cardiopulmonary Care 6 months ago Care Webinars,Webinars Becker muscular dystrophy,cardiac,pulmonary care 123…28»Page 1 of 28